Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection
Chemotherapy. 2021 Mar 23:1-9. doi: 10.1159/000515344. Online ahead of print. PMID: 33756475 Free article. Review.
Infecting intestinal epithelial cells, the severe acute respiratory syndrome coronavirus-2 may impact on host’s microbiota and gut inflammation. It is well established that an imbalanced intestinal microbiome can affect pulmonary function, modulating the host …